GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Short-Term Capital Lease Obligation

Galderma Group AG (XSWX:GALD) Short-Term Capital Lease Obligation : CHF27 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Short-Term Capital Lease Obligation?

Galderma Group AG's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was CHF27 Mil.

Galderma Group AG's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (CHF21 Mil) to Jun. 2024 (CHF23 Mil) and increased from Jun. 2024 (CHF23 Mil) to Dec. 2024 (CHF27 Mil).

Galderma Group AG's annual Short-Term Capital Lease Obligation increased from . 20 (CHF0 Mil) to Dec. 2023 (CHF21 Mil) and increased from Dec. 2023 (CHF21 Mil) to Dec. 2024 (CHF27 Mil).


Galderma Group AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Galderma Group AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Short-Term Capital Lease Obligation Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Short-Term Capital Lease Obligation
20.76 26.75

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Short-Term Capital Lease Obligation - 20.76 23.24 26.75

Galderma Group AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Galderma Group AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Galderma Group AG Business Description

Industry
Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines